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Background.Becauseoftheepidemicofmetabolicsyndrome(MS)inAustralianAboriginalsknownfortheirhighercardiovascular
mortality and shorter life expectancy, we analyzed the possible relationship of their MS risks with the current dietary custom.
Methods. The subjects were 84 people aged 16–79 years. The health examination was conducted according to the basic protocol of
WHO-CARDIAC (Cardiovascular Diseases and Alimentary Comparison) Study. Results. The highest prevalence among MS risks
was abdominal obesity (over 60%). After controlling for age and sex, the odds of obesity decreased signiﬁcantly with high level of
urinary magnesium/creatinine ratio (Mg/cre) (OR, 0.11; 95% CI, 0.02–0.57; P<. 05). The signiﬁcant inverse associations of fat
intake with Mg/cre and of fast food intake with urinary taurine/creatinine ratio were revealed. Conclusions. The high prevalence
of obesity in the Aboriginal people of this area may partly be due to the reduction of beneﬁcial nutrients intake including Mg and
taurine.
1.Introduction
The metabolic syndrome (MS) is composed of cardio-
vascular risk factors including abdominal obesity, high
blood pressure (BP), dyslipidaemia and disturbed glucose
metabolism. The people with MS would be more likely to
havecardiovasculareventsandhaveahigherriskofmortality
[1, 2]. An increased rate of MS in indigenous people than
in nonindigenous people is becoming a serious problem
[3]. Australian Aboriginals have the worse health status
and life expectancy than nonindigenous people. Thompson
et al. reported that a high proportion of urban Aborig-
inals revealed to be smokers, hypertensive, dyslipidaemic,
overweight, obese or diabetes [4]. It was reported that the
percentage of overweight in indigenous Australians was 5.5
times more than that in nonindigenous Australians. The
prevalence of burden of cardiovascular diseases and diabetes
were 4.6 and 5.4 times higher in indigenous people than in
nonindigenous people in 2003 [5]. Both avoidable mortality
and unavoidable mortality in indigenous people were much
higher than those in nonindigenous people in Australia.
The high rate of cardiovascular diseases and obesity
amongAboriginalpeopleisthoughttobecausedbythecom-
bination of several factors including diet change, less activity,
genetic susceptibility, and low level of living standard [5].
They hunted, ﬁshed, and gathered their food depending on
local supply, before the introduction of western-style diets,
high in fat and sugar and low in carbohydrate and nutrients
[6]. They are not seemingly adaptable to the rapid dietary
and lifestyle changes by adjusting their own homeostatic
mechanisms, thus resulting in the development of MS.
Ourobjectiveinthissurveyincludingurinecollectionfor
Australian Aboriginals was to assess the prevalence of MS
risks and their relationship with lifestyle factors especially2 Cardiology Research and Practice
eating habit. Urinary biomarkers such as sodium (Na),
potassium (K), magnesium (Mg), and taurine (Tau) would
reﬂect their eating habit related to health and MS risks,
however,thereisfewreportsaboutthem.Wealsoexpectedto
reveal possible triggers in their diets, if any, for the MS risks.
2. Method
2.1. Subjects. We carried out a health survey in an Aboriginal
community located in Victoria, Australia. Participants were
84 people aged 16 to 79 years who were informed of
the purpose and procedures about the study and signed
an informed consent form. The study included BP and
anthropometrical measurements, blood and spot urine col-
lections and lifestyle questionnaires. This study was ethically
approved by Mukogawa Women’s University and supported
by Framlingham Aboriginal Trust committees.
2.2. Data Collection. All measurements and blood sampling
were performed by an experienced physician and a nurse
at a local community healthcare centre or hospital. Body
weight and height were checked for the subjects standing
and wearing light clothes. From these results, body mass
index (BMI; weight (kg)/height (m)2) was calculated. Waist
circumference (WC) was measured using a ﬂexible steel
measuring tape. BP and heart rates (HR) were measured
after a 5- to 10-minute rest using an automatic digital
BP measurement system (Omron Digital HEM-907, Tokyo,
Japan). The mean of 2 readings was used in this analysis.
Blood analyses including serum total cholesterol (TC),
high-density lipoprotein cholesterol (HDL-C), low-density
lipoprotein cholesterol (LDL-C), triglycerides (TG), fasting
blood glucose, and haemoglobin A1c (HbA1c) were assessed
at Gribbles Pathology (Victoria, Australia). Enzymatic meth-
ods for TC, HDL-C, LDL-C, and TG were performed. Spot
urine was collected using a plastic cup and creatinine, Na,
K, Mg and Tau were analyzed. Na and K were determined
by electrode methods and creatinine was analyzed by
enzymatic method. Mg was analyzed by spectrophotometric
method. Tau was assessed using high performance liquid
chromatography system with ﬂuorescence detection con-
sisted of two pumps (GL-7410, GL science, Tokyo, Japan),
autosampler (GL-7420), and ﬂuorescence detector (GL-
7453A). O-phthalaldehyde solution (containing 5.96mM
O-phthalaldehyde and 0.1% 2-mercaptoethanol in borate
buﬀer) was delivered at 0.5ml/min and ﬁltered urine
samples were injected onto a Hitachi #2619-PH column
(4.0mm i.d.×150mm, Hitachi, Tokyo, Japan). Tau was
monitored using an excitation wavelength of 360nm and
an emission wavelength of 450nm. Sodium-potassium ratio
(Na/K, (mmol/mmol)), sodium-creatinine ratio (Na/cre,
(mmol/g)), potassium-creatinine ratio (K/cre, (mmol/g)),
magnesium-creatinine ratio (Mg/cre, (mg/g)), and taurine-
creatinine ratio (Tau/cre, (μmol/g)) were calculated by the
measured values.
MS risks were deﬁned according to the International
Diabetes Federation (IDF) deﬁnition of the following: abdo-
minal obesity (≥94cm for men or ≥80cm for women); high
TG (≥1.7mmol/L(150mg/dL));lowHDL-C(<1.03mmol/L
(40mg/dL) for men or <1.29mmol/L (50mg/dL) for wo-
men); increased BP (≥130mmHg for systolic or ≥85mmHg
for diastolic). In this survey, high HbA1c (≥5.8%) was used
as a deﬁnition of disturbed glucose metabolism instead of
fasting glucose criteria because it remained possible that
some participants drank soft drinks containing sugar before
starting examination. Dyslipidaemia was deﬁned as elevated
TG and/or low HDL-C. BMI was categorized into 3 groups;
under 25 as normal, 25 or more to under 30 as overweight,
and equal to or over 30 as obesity.
For each participant, eating frequency was assessed
using a food frequency questionnaire about 18 food items
categorizedinto4or5levels:meat,fat,ﬁsh,milk,cheese,egg,
fast food, bread, rice/pasta/noodles, legumes, soy products,
fruits, vegetables, salt, coﬀee, tea, water, and soft drinks.
Furthermore, information regarding employment, educa-
tion, alcohol intake, smoking, medical history and physical
activity were recorded.
2.3. Data Analysis. Diﬀerences between men and women
were investigated using Student’s t-tests. Prevalence rates of
MS risks and intake frequency were compared using chi-
square tests by age divided into 3 categories: young; under 30
years, middle-aged; 30 to 49 years and old; at least 50 years.
Intakefrequencywasclassiﬁedintotwo,high(onceormorea
week)andlow(1,2timesorlessamonth),whichwasapplied
to meat, ﬁsh, vegetables, and fast food. The intake frequency
of soft drinks was classiﬁed into two, high (3 glasses or more
a day) and low (2 glasses or less a day). The fat intake was
categorized to two, “Yes” (eat fat or taken oﬀ after cooking)
and “No” (taken oﬀ before cooking or eat no fat).
To compare urine Na/cre, K/cre, Mg/cre, Tau/cre and
Na/K among three age groups, analyses of one-way variance
was used. Multivariate logistic regression analysis was used
to estimate the odds ratios (ORs) adjusted by age and sex
on MS risks of the level of Na/cre, K/cre, Mg/cre, Tau/cre
and Na/K in urine, which were divided into two groups,
high and low, at the mean value. Diﬀerences in MS risks
were investigated using Student’s t-tests between high and
low of urine Mg/cre and Tau/cre. The association of intake
frequency to Mg/cre and Tau/cre was examined by a logistic
regression adjusted with age and sex.
AllstatisticalanalyseswereundertakenusingtheSPSSfor
windows package version 15 (SPSS Inc, Chicago, IL). Results
are presented as means ± standard deviations. A P-value
of.05 was set as the level of signiﬁcance.
3. Results
3.1. Characteristics of the Study Population. Fifty percent of
the total study subjects (n = 84) were men. Two men were
excluded from all analyses because of the lack in blood and
urine sampling. Urinary data of a man who did not provide
adequate results was also eliminated. Baseline characteristics
of study subjects are shown in Table 1. The mean age was 42
years for men (range, 16–77 years) and 37 years for women
(range, 16–79 years). Men showed signiﬁcantly higher levels
in TC, LDL-C and SBP than women. The Na/Cre, K/Cre,Cardiology Research and Practice 3
Table 1: Characteristics of study subjects.
All Men Women P-value
Biological variables (n=82) (n=40) (n=42)
Age (year) 39.6±17.6 42.0±18.2 37.4±17.0 .23
BMI (kg/m2) 28.2±6.1 27.4±4.7 28.9±7.1 .27
WC (cm) 96.6±14.5 94.5±12.5 98.6±16.0 .20
SBP (mmHg) 130.4±16.4 135.3±17.0 125.7±14.5 <.01
DBP (mmHg) 73.9±11.9 76.0±12.4 72.0±11.2 .12
HR (bpm) 75.8±15.4 75.0±16.6 76.6±14.3 .65
TC (mmol/L) 4.6±1.1 4.9±1.2 4.3±1.0 <.05
HDL-C (mmol/L) 1.2±0.2 1.2±0.2 1.2±0.3 .60
LDL-C (mmol/L) 2.8±1.0 3.1±1.0 2.5±0.9 <.01
TG (mmol/L) 1.5±0.9 1.4±0.7 1.5±1.0 .69
HbA1c (%) 5.9±0.9 5.8±0.5 6.1±1.2 .11
Ratios in urine (n=79) (n=38) (n=41)
Na/cre (mmol/g) 94.5±60.2 86.0±56.7 102.3±62.9 .23
K/cre (mmol/g) 55.7±28.4 53.7±28.6 57.6±28.4 .54
Mg/cre (mg/g) 44.9±23.1 42.1±25.3 47.6±20.9 .30
Tau/cre (μmol/g) 1122.8±2674.9 1590.3±3770.8 689.5±631.9 .14
Na/K (mol/mol) 1.97±1.65 1.89±1.55 2.04±1.76 .69
Data are mean±SD.
Mg/Cre, Tau/cre and Na/K ratios did not diﬀer between the
sex groups.
3.2. Age-Speciﬁc Prevalence. The frequency of MS risks and
eating habit proﬁles among three age groups are presented in
Figure 1 and Table 2. The highest percentage of obesity was
shown in the old (young; 23.3%, middle-aged; 21.4%, old;
37.5%) and quite high frequency of abdominal obesity was
shown at any age group (young; 66.7%, middle-aged; 67.9%,
old; 66.7%). The prevalence of increased BP rose with age,
from 60% of the young to 75% of the old, as well as high
HbA1c, from 20% of the young to 62.5% of the old. On the
other hand, the percentages of low HDL-C (41.7%) and high
TG(25.0%)intheoldwerelowestofall,whichresultedinthe
lowest percentage of dyslipidaemia (young; 66.7%, middle-
aged; 67.9%, old; 50%, data not shown). Table 2 shows the
dietary pattern of participants among age groups. The intake
frequency of vegetables in the young was lower and that of
soft drinks was higher than other age groups (P<. 01 for
both). On the other hand, the intake frequencies of meat
and fast food in the old were signiﬁcantly lower than those
in younger groups (P<. 05 and P<. 001, resp.).
3.3. Urine Analyses. Table 3 shows logistic regression results
of obesity and dyslipidaemia with urinary biomarkers
adjusted with age and sex. High level of urine Mg/cre was
associated with a much lower likelihood of obesity (OR,
0.11; 95%CI, 0.02–0.57; P<. 05). Logistic regression results
adjusted with age and sex on subjects with dyslipidaemia
showed a signiﬁcantly lower OR in the high level of urine
Tau/cre (OR, 0.22; 95%CI, 0.07–0.73). High Tau/cre was
associated with low TG (P<. 05) and showed a tendency
to be related with low WC and BMI (P = .06 and.09, resp.;
Table 4). Table 5 shows the relationship of urine Mg/cre and
Tau/crewitheatinghabitsbylogisticregressionadjustedwith
age and sex. Compared to subjects who eat no fat, those who
eat fat had a signiﬁcantly lower likelihood of high Mg/cre
level(OR,0.12;95%CI,0.02–0.59)andasimilarrelationship
wasshownbetweenintakefrequencyoffastfoodandTau/cre
level (OR, 0.11; 95%CI, 0.02–0.69).
4. Discussion
This study is the ﬁrst to report on the relationship of MS
risks with eating habit by spot urine analysis of nutritional
biomarkers including Mg and Tau in Australian Aboriginals.
It revealed a high prevalence of MS including abdominal
obesity, increased BP and low HDL-C even at young age,
and a quite high prevalence of high HbA1c in the old. The
study conﬁrms that an increased level of Mg/cre in spot
urine is associated with a decreased likelihood of obesity,
supported by lower BMI and WC in people with a higher
level of Mg/cre. Restriction of magnesium intake decreased
urinaryloss[7]andagoodcorrelationwasobservedbetween
Mg/cre in spot urine and total 24-hour urine excretion (R =
0.80, P<. 05) [8]. Considering both, low level of Mg/cre
in spot urine would be caused by insuﬃcient Mg intake
and our ﬁnding is consistent to the previous studies that
higher intake of Mg was associated with a marked reduction
in the prevalence of obesity (OR, 0.78; 95%CI, 0.72–0.85),
abdominal obesity (OR, 0.80; 95%CI, 0.76–0.85), and MS
(OR, 0.83; 95%CI, 0.72–0.96) in the US people [9]. As it is4 Cardiology Research and Practice
Table 2: Eating frequency by age groups.
Age Young Middle-
aged Old P-value
(Men/Women) n=30
(13/17)
n=28
(13/15)
n=24
(14/10)
Meat <.05
Low 30.0 (9) 28.0 (7) 58.3 (14)
High 70.0 (21) 72.0 (18) 41.7 (10)
Fat .56
No 36.0 (18) 30.0 (15) 34.0 (17)
Yes 35.7 (10) 39.3 (11) 25.0 (7)
Fish .53
Low 46.7 (14) 32.0 (8) 37.5 (9)
High 53.3 (16) 68.0 (17) 62.5 (15)
Vegetables <.01
Low 93.3 (28) 76.0 (19) 56.5 (13)
High 6.7 (2) 24.0 (6) 43.5 (10)
Fruits .74
Low 20.0 (6) 16.0 (4) 25.0 (6)
High 80.0 (24) 84.0 (21) 75.0 (18)
Fast food <.001
Low 20.0 (6) 28.0 (7) 70.8 (17)
High 80.0 (24) 72.0 (18) 29.2 (7)
Soft drinks <.01
Low 36.0 (9) 68.4 (13) 80.0 (16)
High 64.0 (16) 31.6 (6) 20.0 (4)
Data are percentage (n). Young; under 30 years, Middle-aged; 30 to 49 years,
Old; 50 years and older.
Table 3: Adjusted odds ratios of obesity and dyslipidaemia
according to urinary biomarkers.
Obesity Dyslipidaemia
OR (95%CI) P-value OR (95%CI) P-value
Na/cre Low 1 1
High 0.31 (0.08–2.26) .31 0.75 (0.19–3.02) .69
K/cre Low 1 1
High 1.81 (0.39–8.40) .45 0.56 (0.15–2.04) .38
Mg/cre Low 1 1
High 0.11 (0.02–0.57) <.05 0.82 (0.27–2.48) .73
Na/K Low 1 1
High 5.68
(1.00–32.33) .05 1.02 (0.25–4.20) .98
Tau/cre Low 1 1
High 0.36 (0.08–1.71) .20 0.22 (0.07–0.73) <.05
Data are adjusted by age and sex.
known, Mg is essential to many enzymatic reactions across
themetabolic pathway of carbohydrate, lipid and electrolytes
as a cofactor [10], and obesity is strongly inversely related to
magnesium deﬁciency [11]. This may be partly due to the
eatinghabitofobesepeopleandthelowconsumptionofrich
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Figure 1: Prevalence of MS risks by age groups. young: under 30
years, middle-aged: 30 to 49 years, Old: 50 years and older. Obesity:
BMI ≥ 30, abdominal obesity: ≥94cm for men or ≥80cm for
women, Increased BP: ≥130mmHg for systolic or ≥85mmHg for
diastolic, low HDL-C: <1.03mmol/L, high TG: ≥1.7mmol/L, high
HbA1c: ≥5.8%.
in Mg foods such as whole grains, vegetables and seafood.
The renal loss may be another mechanism contributing to
Mg deﬁciency in obese people. Insulin plays a role in induc-
ingMgexcretion[12].Insulinresistanceisthemostcommon
and could increase Mg excretion in people with MS risks
[13].
In this study, urine Mg/cre was inversely associated with
fat intake. It is reported that saturated fatty acids can cause
a lipid-created plasma membrane abnormality because of
incorporation into the cell membrane and the transition
of Mg into cell may be reduced [14]. An accumulation
of saturated fatty acids by diet may cause depletion of
intracellular Mg, which might lead to diabetes [15]. Previous
studies revealed that Mg deﬁciency was correlated with
diabetes in indigenous Australians and US women [16,
17]. However, our study showed no signiﬁcant association
between urine Mg/cre and HbA1c. A possible reason is that
HbA1c is a long-term indicator of hyperglycaemia, whereas,
urine Mg/cre is a short-term indicator of diet.
Urine Tau/cre was associated with a decreased likelihood
of dyslipidaemia. Fish is abundant source of Tau [18, 19]
and omega-3 fatty acid. It was reported that the frequency
of ﬁsh intake was positively correlated with the percent
composition of omega-3 fatty acid in plasma phospholipids
and negatively correlated with TC and LDL-C [20]. Fish oil
such as eicosapentaenoic acid and docosahexaenoic acid are
well known to lower the TG level [21]. The beneﬁcial eﬀects
of Tau on lipid metabolism, such as hypocholesterolaemic
and hypotriglyceridaemic activities, were observed both in
rats and in humans [22, 23]. There was no signiﬁcantCardiology Research and Practice 5
Table 4: MS risks according to urine levels of Mg/cre and Tau/cre.
Mg/cre Tau/cre
Low High P-value Low High P-value
BMI (kg/m2) 29.4±6.3 26.1±4.6 <.05 28.9±6.1 26.4±5.0 .09
WC (cm) 99.1±14.6 91.8±11.9 <.05 98.4±14.3 91.8±12.3 .06
SBP (mmHg) 128.1±15.4 134.4±18.0 .10 131.7±17.7 128.3±14.2 .41
DBP
(mmHg) 74.1±13.4 73.1±9.7 .73 74.3±11.8 72.4±12.8 .53
HR (bpm) 75.9±14.5 75.7±16.4 .95 74.5±11.0 79.5±11.0 .19
TC (mmol/L) 4.5±1.2 4.8±0.9 .40 4.7±1.1 4.4±1.1 .29
HDL-C
(mmol/L) 1.2±0.3 1.2±0.2 .65 1.2±0.3 1.2±0.2 .55
LDL-C
(mmol/L) 2.7±1.1 2.9±0.8 .57 2.8±1.0 2.7±1.0 .52
TG (mmol/L) 1.4±0.7 1.6±1.0 .19 1.6±0.9 1.2±0.6 <.05
HbA1c (%) 6.0±1.1 5.8±0.6 .51 6.0±1.1 5.7±0.3 .15
Data are mean±SD.
Table 5: Adjusted odds ratios of urine Mg/cre and Tau/cre according to eating habit.
High Mg/cre High Tau/cre
OR (95%CI) P-value OR (95%CI) P-value
Meat Low 1 1
High 1.07 (0.19–6.05) .94 2.06 (0.33–12.82) .44
Fat No 1 1
Yes 0.12 (0.02–0.59) <.01 0.24 (0.04–1.30) .10
Fish Low 1 1
High 1.69 (0.42–6.83) .46 3.17 (0.63–16.08) .16
Vegetables Low 1 1
High 1.87 (0.37–9.51) .45 1.27 (0.20–8.06) .80
Fruits Low 1 1
High 1.18 (0.20–6.77) .86 0.31 (0.05–2.15) .24
Fast food Low 1 1
High 0.80 (0.17–3.90) .78 0.11 (0.02–0.69) <.05
Soft drinks Low 1 1
High 1.16 (0.29–4.71) .83 0.93 (0.20–4.38) .92
Data are adjusted by age and sex.
association between elevated urine Tau/cre and obesity in
this study. However, the subjects with high Tau/cre showed
a weak tendency to be low BMI and WC, which is supported
by the previous study showing that Tau prevented obesity in
high-fat-induced and/or genetically obese mice [24].
Contrary to our expectation, no association was detected
between the intake frequency of ﬁsh and Tau/cre. It may
be due to out of consideration to the volume of ﬁsh
consumption and the lack of question about seafood other
than ﬁsh, especially to shellﬁsh, the most abundant source
of Tau. Furthermore, no association was detected between
Tau/cre and HbA1c in this study. Our previous report
revealed that the excretion volume of Tau in 24-hour urine
wasinverselyassociatedwithfastingbloodglucoseinAfrican
men [25]. A population-based prospective cohort study
in England also showed that ﬁsh consumption would be
eﬀective in reducing risk of diabetes [26]. The same reason
for the lack of relationship between Mg/cre and HbA1c in
this study is supposed to be applicable to between Tau/cre
and HbA1c again.
Aboriginal people used to eat Mg rich food, such as
nuts, vegetables, and unreﬁned cereals. These plant foods
also contain other minerals, vitamins, ﬁbre, and omega-
3 fatty acids [27]. Their modern diet, however, includes
foods that are rich in fat and sugar, which may result in
excessive energy intake and unhealthy condition. This study
revealedAboriginalpeopleinthisareawereatextremelyhigh
risks of abdominal obesity, consistent with health report in6 Cardiology Research and Practice
AustralianAboriginals[5].Ourdataalsoconﬁrmedprevious
ﬁndings from the DRUID (Diabetes and Related conditions
in Urban Indigenous people in the Darwin region) study
that the percentages of increased BP and TC in men were
higherthaninwomenandthattheprevalenceofdiabetesand
the mean of HbA1c rose strongly with age [28]. Aboriginals
also used to have eating habit of ﬁsh and shellﬁsh [6].
However, this study showed that the ﬁsh intake frequency
in nearly the half of the subjects was less than once a week.
The inverse relationship between Tau/cre and the intake
frequency of fast food, as well as between Mg/cre and fat
intake, would demonstrate that Western eating habit have
caught on in this area. The percentage of high TG showed no
association with age, which may be accounted for by lower
eating frequencies of meat and fast food and a higher eating
frequencyofvegetablesintheoldthaninboththeyoungand
middle aged. These results from eating frequency revealed
increasing westernization of diet in the young and middle-
aged, indicating the increase of diabetes in future.
Recently, Yamori et al. reported that Mg and Tau showed
a synergistic eﬀect on preventing cardiovascular risks [29].
Tau is an abundant and semiessential free amino acid in
human and has beneﬁcial eﬀects on MS risks such as
hypertension, dyslipidaemia, and diabetes [30]. Previous
reports showed Mg intake was inversely associated with
the incidence of ischemic stroke [31]. Beneﬁcial eﬀects on
endothelial function of Mg, and Tau were also reported
[32, 33]. To prevent MS risks, it would be recommended to
promote diet rich in Mg and Tau to Australian Aboriginals.
There are some limitations in this study. First, the
number of the participants was small and age showed wide
variance,yetthenumberandmeanageofeachsexwasnearly
equal. Secondly, it was impossible to analyze the excretion
volume of Na, K, Mg and Tau a day because the number of
participants successful in a collection of 24-hour urine was
inadequate. Consequently, we analyzed those excretion levels
of spot urine instead of 24-hour urine, because the good
correlation between creatinine ratio of Tau in spot urine and
the total volume in 24-hour urine was detected in previous
study [34]a sw e l la sM g[ 8]. We supposed that Mg/cre and
Tau/cre in spot urine could be useful for alternative markers
of one-day excretion volume of Mg and Tau respectively and
that could be available for evaluating risks of coronary heart
diseases and diabetes.
The main implication of our results is that low urinary
Mg and Tau levels predict increased MS risks in Australian
Aboriginals. Mg deﬁciency would lead less activity of enz-
ymes and insulin resistance. Tau has beneﬁcial eﬀects for lip-
id metabolisms. In addition, both Mg and Tau have cardio-
protective and antihypertensive eﬀects. These data support
the hypothesis that diet rich in Mg and Tau may help to pre-
vent MS risks. It is needed to conﬁrm the association of Mg
andTauwithMSrisksinadditionallargeprospectivestudies.
5. Conclusion
In conclusion, low urine Mg/cre and/or Tau/cre could be
associated with MS prevalence in Australian Aboriginals, in
part, via the eﬀects on obesity and dyslipidaemia.
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